Valuation Amgen Inc. Xetra

Stocks

Market Closed - Xetra Other stock markets 11:35:33 2026-06-15 EDT			After hours 16:00:01
306.15 ^EUR	-0.05%		302.60	-1.16%

01:57pm	Mizuho Securities Lifts Price Target on Amgen to $303 From $295, Keeps Outperform Rating	MT
06:56am	Global drugmakers invest billions to boost US presence	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	191,704	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	8.77%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	232,936	226,787	221,259
Change	-	11.7%	22.4%	-9.42%	17.8%	5.06%	-2.64%	-2.44%
P/E Ratio	21.9x	21.7x	23.1x	34.5x	23x	23.1x	21x	20x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	17.2x	13.7x	10.9x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.86x	2.12x	4.17x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.07x	4.95x	4.83x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.16x	5.85x	5.57x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	10.8x	10.5x	10.5x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	14.1x	13.3x	12.7x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	17.3x	15x	14.5x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	5.77%	6.66%	6.92%
Dividend per Share ²	7.04	7.76	8.52	9	-	10.09	10.66	11.13
Rate of return	3.13%	2.95%	2.96%	3.45%	-	2.84%	3%	3.13%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.38	16.91	17.72
Distribution rate	68.5%	64.1%	68.2%	119%	-	65.6%	63%	62.8%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	37,794	38,753	39,716
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,638	21,587	21,007
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,512	17,022	17,474
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,265	9,041	9,541
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,232	35,083	29,554
Reference price ²	224.97	262.64	288.02	260.64	327.31	355.20	355.20	355.20
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	539,708	-	-
Announcement Date	2/7/22	1/31/23	2/6/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.75x	9.72x	3.95%	197B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
PFIZER INC.	12.26x	3.2x	7.8x	6.68%	149B
Average	14.27x	5.86x	15.53x	2.98%	376.27B
Weighted average by Cap.	22.19x	7.36x	17.37x	2.25%